Sirirat Nakdang

At the clinic, Dr. Tuksaorn Suriyakan (“Ping”) is positioned as an Anti-Aging & Regenerative Medicine physician who builds longevity plans around medical supervision and follow-up. As a specialist at the clinic, she leads doctor-led consultations for peptide therapies and preventive medicine, including recovery and healing protocols. The clinic emphasizes that peptide dosing is individualized and supervised, and it does not publish DSIP dosing online because it must be tailored case-by-case. Her peptide offerings discussed at the clinic include DSIP for sleep and stress-response hypotheses, LL-37 for immune coordination and antimicrobial activity studied in preclinical settings, and SS-31 (Elamipretide) for mitochondrial energy support and oxidative-stress related pathways. For Ipamorelin, the clinic describes prescriptions filled by a licensed compounding pharmacy partner and follow-up consultations every 4–6 weeks to assess response and safety. Oxytocin is described as a supervised trial, with review of response before continuing. The clinic also frames peptide selection through research-informed positioning and case-by-case suitability, with contraindications and safety boundaries discussed during consultation.

Education

Not listed on the clinic pages.

Work experience

• 8 years of experience — Anti-Aging & Regenerative Medicine Physician (as stated on the clinic pages).

Clinical focus and techniques

As a specialist at the clinic, Dr. Tuksaorn Suriyakan’s documented focus includes longevity, preventive medicine, and doctor-supervised peptide therapy. The clinic lists the following therapies and care elements:

• DSIP (Delta Sleep-Inducing Peptide) therapy — doctor-led consultation; dosing individualized and supervised.
• LL-37 peptide therapy — discussed as research-stage immune and antimicrobial activity.
• SS-31 (Elamipretide) peptide therapy — mitochondrial energy support and oxidative-stress research pathways.
• KPV peptide therapy — physician decides route (subcutaneous injection, oral capsule, or topical) based on goal.
• BPC-157 peptide therapy — compounded by a licensed pharmacy partner and monitored monthly.
• Ipamorelin peptide therapy — follow-up consultations every 4–6 weeks to assess response and safety.
• Oxytocin therapy — treated as a supervised trial with review before continuing.
• Additional longevity protocols discussed at the clinic include NAD+ therapy and Mots-C, Hexarelin, GHRP-6, ARA-290 (Cibinetide), Thymosin Alpha-1, Tesofensine, and AOD-9604 as part of broader metabolic or longevity plans.

Professional societies and certifications

Not listed on the clinic pages.

Academic output

Not listed on the clinic pages.

Awards and recognition

Not listed on the clinic pages.

Courses and advanced training

Not listed on the clinic pages.

For international patients, the clinic describes doctor-led consultations and structured follow-up in Bangkok, with therapy decisions based on medical history and safety boundaries. The clinic also positions alternatives to peptide therapy as part of the consultation, including lifestyle modifications and other advanced options when appropriate.